AOD-9604 10mg

Description

AOD‑9604 is a synthetic peptide fragment derived from the C‑terminal end of human growth hormone (HGH 176‑191). It is widely studied for its potential role in fat metabolism, lipolysis, cellular energy regulation, and metabolic function research. This peptide is frequently used in controlled laboratory settings to explore pathways related to fat oxidation, adipose tissue signaling, and metabolic homeostasis.

Key Features

• High‑purity AOD‑9604 peptide
• Fragment of HGH 176‑191 used in metabolic research
• Studied for lipolysis and fat‑oxidation pathways
• Manufactured in a sterile, research‑grade facility
• HPLC‑verified purity
• Non‑biological, non‑viable, and not for human use

Main Research Benefits

• Lipolysis Pathway Research — AOD‑9604 is frequently studied for its potential role in stimulating fat‑breakdown pathways without affecting blood glucose levels.
• Metabolic Regulation Studies — Researchers explore its impact on metabolic signaling, energy expenditure, and adipocyte activity.
• Fat Oxidation Mechanisms — Investigated for its ability to support fatty‑acid mobilization and oxidation in controlled environments.
• Cellular Energy Research — Used to study mitochondrial activity and metabolic homeostasis.
• HGH Fragment Comparison Studies — Enables comparative research between full‑length HGH and its isolated 176‑191 fragment.

Peptide Storage

• Avoid light exposure
• Do not store peptides in solution long-term
• Long term storage – you can store for up to 2 years in the freezer
• Avoid repeated freezing and thawing of the peptide
• Store peptide in a cold, dry, dark place

 Important Notice

Opeptides sells all products only for laboratory research. Researchers must use these materials in controlled research settings and never for human or animal use. Do not consume, inject, or apply these products. Do not use them to diagnose, treat, cure, or prevent any disease.  You also cannot use Opeptides products in foods, drugs, cosmetics, medical devices, or any clinical environment. All information on this site supports education and research, not medical guidance. The U.S. Food and Drug Administration has not evaluated any statements on this website.

Opeptides operates strictly as a chemical supplier. We do not act as a compounding pharmacy or a chemical compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act. We also do not operate as an outsourcing facility under Section 503B. Researchers must follow all laws, regulations, and safe laboratory practices when using our products.